about
Circulating MicroRNAs as Biomarkers in Biliary Tract CancersEmerging Role of miRNAs in the Drug Resistance of Gastric CancerMolecular classification of gastric cancer: Towards a pathway-driven targeted therapyLoss of Expression of Reprimo, a p53-induced Cell Cycle Arrest Gene, Correlates with Invasive Stage of Tumor Progression and p73 Expression in Gastric CancerCMS: a web-based system for visualization and analysis of genome-wide methylation data of human cancersSerial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer.Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomasHeregulin Co-opts PR Transcriptional Action Via Stat3 Role As a Coregulator to Drive Cancer Growth.Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer.Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer.Complete pathological response to Imatinib mesylate in an extraintestinal gastrointestinal stromal tumorThe Axl receptor tyrosine kinase is an adverse prognostic factor and a therapeutic target in esophageal adenocarcinomaGenome-wide DNA methylation analysis reveals estrogen-mediated epigenetic repression of metallothionein-1 gene cluster in breast cancer.Macrophage migration inhibitory factor - a therapeutic target in gallbladder cancer.Clinical and public health research using methylated DNA immunoprecipitation (MeDIP): a comparison of commercially available kits to examine differential DNA methylation across the genomeGallbladder cancer: expert consensus statement.Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinoma.Overexpression of ribosome binding protein 1 (RRBP1) in breast cancer.Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics.Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line.Overexpression of Kinesin Associated Protein 3 (KIFAP3) in Breast CancerRapamycin and WYE-354 suppress human gallbladder cancer xenografts in miceStudy protocol for the Maule Cohort (MAUCO) of chronic diseases, Chile 2014-2024Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways.AKT/mTOR substrate P70S6K is frequently phosphorylated in gallbladder cancer tissue and cell lines.RNA sequencing-based analysis of gallbladder cancer reveals the importance of the liver X receptor and lipid metabolism in gallbladder cancerSalmonella enterica serovar Typhi and gallbladder cancer: a case-control study and meta-analysis.Gallbladder cancer: a morphological and molecular update.Virulence of infecting Helicobacter pylori strains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae.Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean populationProgesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy.[Frequency of Chlamydia trachomatis infection in a group of women from Region of Araucanía, Chile].Pathologic staging of pancreatic, ampullary, biliary, and gallbladder cancers: pitfalls and practical limitations of the current AJCC/UICC TNM staging system and opportunities for improvement.Targeting specific molecular pathways holds promise for advanced gallbladder cancer therapy.Quantitative phosphoproteomic analysis of IL-33-mediated signalingReprimo, a Potential p53-Dependent Tumor Suppressor Gene, Is Frequently Hypermethylated in Estrogen Receptor α-Positive Breast Cancer.Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.The Gene Expression Status of the PI3K/AKT/mTOR Pathway in Gastric Cancer Tissues and Cell Lines.The inflammatory inception of gallbladder cancer.
P50
Q26746000-0655DFE6-28F8-4A07-B126-EE1089CFCB2FQ26752006-4E045677-CB79-4AC7-BDBF-4A3EBE097627Q26798420-A2C4C7F6-6D15-4C4F-BDBB-DBCFFA8B9C4EQ28261753-4EB8599C-AE56-41A9-B5F5-0865B72AB2F3Q30620572-6EDC79A8-137B-43F0-8C82-75812B56428FQ33331290-22C9BB2F-8DD7-49C1-B634-D54509AAEABFQ33581027-EBC2A214-BB9A-4A4D-AF3C-961547D42156Q33631532-DC314992-5E34-4611-B858-56F9B4000707Q33688577-2A86DFE7-9058-4971-9914-978B0E51CC5AQ34166938-1BD936C6-80DF-42CD-A4AA-155AEE1A8C1BQ34305765-43A8AE43-74A3-4597-A7E7-6668F4F7304AQ34515144-5BA1B507-4C07-46E2-A568-8420839F1708Q35166554-6353D83F-44C4-4A4F-9557-28EF98BC9B11Q35830961-2AC72512-9281-47C2-9FEC-3EEBF74C46E7Q35916101-E80A2305-2C93-40A8-86EE-33ACF0C534ABQ35924976-0A4A5705-0A54-4D9E-A01C-D45BD9B95B29Q36055277-255CEBF5-E139-45BD-982F-1D72F68438A6Q36213122-FB683EE5-4E39-4059-863A-C7B27D317E9FQ36226745-C665A2FE-EEE9-4213-BBC9-C78D4F83E19FQ36416431-4D6A0F8F-45EB-483A-8656-A4DFB55BD7F7Q36489832-DDE09A59-DEAD-4ACD-BA7B-CA4B577629DFQ36525056-499FFD2D-E49B-4FB1-8AF9-0CE008A98DC0Q36544718-D2C0FE8C-07BF-418A-9B19-BBEBFA5C597BQ36550354-40BC2BC1-C838-4F7F-BD17-CC22AAB4DF0CQ36557240-EC9A2BF7-AB80-43F2-9DD1-274CA93C832BQ37225342-CAE2757D-46ED-4D64-8C80-248A6BC197CAQ37376541-78C99CF6-EABB-4569-8FB7-E2E9B9DEFC83Q37430026-73DD8E32-2D0C-4E47-9E91-6D03661DE01FQ37505245-E9AAEB26-52AA-44CA-BECA-2A1039A15A80Q37590751-D8E51833-8EAA-4D70-9862-DC2A5DF5ED9EQ37655869-26EBD574-50D5-46BB-A660-DDEBFA10FED9Q37690705-DF6952D6-573A-407F-88A0-CC9BEC088EF5Q37844926-8FCAD652-D515-4A2D-A9AC-38E8F3F3D03AQ38051780-7DB9785B-7A0F-449D-808F-7E7DCA6AB01BQ38339507-34455B8A-4156-461F-8B88-DC63CC02ECAAQ38421390-35BF7B3A-2107-407D-8BF7-8AB78CE69FB3Q38623918-141329B0-A02A-4911-A83A-BCE192C9D476Q38642905-7632EEB3-8915-4684-9E81-0C618DCE8012Q38772498-D3F1C296-C9D9-48CD-B819-13F125FF3572Q38776213-F9A13119-2DA1-4327-96BC-AED72E57F4DC
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Juan Carlos Roa
@ast
Juan Carlos Roa
@en
Juan Carlos Roa
@es
Juan Carlos Roa
@nl
Juan Carlos Roa
@sl
type
label
Juan Carlos Roa
@ast
Juan Carlos Roa
@en
Juan Carlos Roa
@es
Juan Carlos Roa
@nl
Juan Carlos Roa
@sl
prefLabel
Juan Carlos Roa
@ast
Juan Carlos Roa
@en
Juan Carlos Roa
@es
Juan Carlos Roa
@nl
Juan Carlos Roa
@sl
P106
P1153
7003655046
P21
P31
P496
0000-0001-8313-8774